|
1
|
Chung HW and Lim JB: Role of the tumor
microenvironment in the pathogenesis of gastric carcinoma. World J
Gastroenterol. 20:1667–1680. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qiu MZ and Xu RH: The progress of targeted
therapy in advanced gastric cancer. Biomark Res. 1:322013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li Q, Wang L, Tan W, Peng Z, Luo Y, Zhang
Y, Zhang G, Na D, Jin P, Shi T, et al: Identification of
C1qTNF-related protein 4 as a potential cytokine that stimulates
the STAT3 and NF-kappaB pathways and promotes cell survival in
human cancer cells. Cancer Lett. 308:203–214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Akiyama H, Furukawa S, Wakisaka S and
Maeda T: CTRP3/cart-ducin promotes proliferation and migration of
endothelial cells. Mol Cell Biochem. 304:243–248. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park SY, Choi JH, Ryu HS, Pak YK, Park KS,
Lee HK and Lee W: C1q tumor necrosis factor alpha-related protein
isoform 5 is increased in mitochondrial DNA-depleted myocytes and
activates AMP-activated protein kinase. J Biol Chem.
284:27780–27789. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peterson JM, Wei Z and Wong GW:
C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates
hepatic glucose output. J Biol Chem. 285:39691–39701. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chavali VR, Khan NW, Cukras CA, Bartsch
DU, Jablonski MM and Ayyagari R: A CTRP5 gene S163R mutation
knock-in mouse model for late-onset retinal degeneration. Hum Mol
Genet. 20:2000–2014. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hofmann C, Chen N, Obermeier F, Paul G,
Buchler C, Kopp A, Falk W and Schäffler A: C1q/TNF-related
protein-3 (CTRP-3) is secreted by visceral adipose tissue and
exerts antiinflammatory and antifibrotic effects in primary human
colonic fibroblasts. Inflamm Bowel Dis. 17:2462–2471. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thanasupawat T, Glogowska A, Burg M, Wong
GW, Hoang-Vu C, Hombach-Klonisch S and Klonisch T: RXFP1 is
targeted by complement C1q tumor necrosis factor-related factor 8
in brain cancer. Front Endocrinol (Lausanne). 6:1272015. View Article : Google Scholar
|
|
10
|
Klonisch T, Glogowska A, Thanasupawat T,
Burg M, Krcek J, Pitz M, Jaggupilli A, Chelikani P, Wong GW and
Hombach-Klonisch S: Structural commonality of C1q TNF-related
proteins and their potential to activate relaxin/insulin-like
family peptide receptor 1 signalling pathways in cancer cells. Br J
Pharmacol. 174:1025–1033. 2017. View Article : Google Scholar
|
|
11
|
Glogowska A, Kunanuvat U, Stetefeld J,
Patel TR, Thanasupawat T, Krcek J, Weber E, Wong GW, Del Bigio MR,
Hoang-Vu C, et al: C1q-tumour necrosis factor-related protein 8
(CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in
human brain cancer cells. J Pathol. 231:466–479. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takeuchi T, Adachi Y and Nagayama T:
Expression of a secretory protein C1qTNF6, a C1qTNF family member,
in hepatocellular carcinoma. Anal Cell Pathol (Amst). 34:113–121.
2011. View Article : Google Scholar
|
|
13
|
Wu WJ, Mo DL, Zhao CZ, Zhao C, Chen YS,
Pang WJ and Yang GS: Knockdown of CTRP6 inhibits adipogenesis via
lipogenic marker genes and Erk1/2 signalling pathway. Cell Biol
Int. 39:554–562. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Murayama MA, Kakuta S, Inoue A, Umeda N,
Yonezawa T, Maruhashi T, Tateishi K, Ishigame H, Yabe R, Ikeda S,
et al: CTRP6 is an endogenous complement regulator that can
effectively treat induced arthritis. Nat Commun. 6:84832015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fan RH, Zhu XM, Sun YW, Peng HZ, Wu HL and
Gao WJ: CTRP6 inhibits fibrogenesis in TGF-beta1-stimulated human
dermal fibroblasts. Biochem Biophys Res Commun. 475:356–360. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Chen Z, He T, Zhao K and Xing C:
Anti-metastatic activity of fangchinoline in human gastric cancer
AGS cells. Oncol Lett. 13:655–660. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schaffler A and Buechler C: CTRP family:
Linking immunity to metabolism. Trends Endocrinol Metab.
23:194–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang C, Gao C, Zhuang JL, Ding C and Wang
Y: A combined approach identifies three mRNAs that are
down-regulated by microRNA-29b and promote invasion ability in the
breast cancer cell line MCF-7. J Cancer Res Clin Oncol.
138:2127–2136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim MJ, Lee W, Park EJ and Park SY:
C1qTNF-related protein-6 increases the expression of interleukin-10
in macrophages. Mol Cells. 30:59–64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu M, Ludlow D, Alexander JS, McLarty J
and Lian T: Improved wound healing of postischemic cutaneous flaps
with the use of bone marrow-derived stem cells. Laryngoscope.
124:642–648. 2014. View Article : Google Scholar
|
|
22
|
Peranteau WH, Zhang L, Muvarak N, Badillo
AT, Radu A, Zoltick PW and Liechty KW: IL-10 overexpression
decreases inflammatory mediators and promotes regenerative healing
in an adult model of scar formation. J Invest Dermatol.
128:1852–1860. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ahima RS, Qi Y, Singhal NS, Jackson MB and
Scherer PE: Brain adipocytokine action and metabolic regulation.
Diabetes. 55(Suppl 2): S145–S154. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Scherer PE, Williams S, Fogliano M,
Baldini G and Lodish HF: A novel serum protein similar to C1q,
produced exclusively in adipocytes. J Biol Chem. 270:26746–26749.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kopp A, Bala M, Weigert J, Buchler C,
Neumeier M, Aslanidis C, Scholmerich J and Schaffler A: Effects of
the new adiponectin paralogous protein CTRP-3 and of LPS on
cytokine release from monocytes of patients with type 2 diabetes
mellitus. Cytokine. 49:51–57. 2010. View Article : Google Scholar
|
|
26
|
Sun Y, Yi W, Yuan Y, Lau WB, Yi D, Wang X,
Wang Y, Su H, Wang X, Gao E, et al: C1q/tumor necrosis
factor-related protein-9, a novel adipocyte-derived cytokine,
attenuates adverse remodeling in the ischemic mouse heart via
protein kinase A activation. Circulation. 128(11 Suppl 1):
S113–S120. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bai S, Cheng L, Yang Y, Fan C, Zhao D, Qin
Z, Feng X, Zhao L, Ma J, Wang X, et al: C1q/TNF-related protein 9
protects diabetic rat heart against ischemia reperfusion injury:
Role of endoplasmic reticulum stress. Oxid Med Cell Longev.
2016:19020252016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Y, Geng X, Wang H, Cheng G and Xu S:
CTRP9 ameliorates pulmonary arterial hypertension through
attenuating inflammation and improving endothelial cell survival
and function. J Cardiovasc Pharmacol. 67:394–401. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hou M, Liu J, Liu F, Liu K and Yu B: C1q
tumor necrosis factor-related protein-3 protects mesenchymal stem
cells against hypoxia- and serum deprivation-induced apoptosis
through the phosphoinositide 3-kinase/Akt pathway. Int J Mol Med.
33:97–104. 2014. View Article : Google Scholar
|
|
30
|
Yi W, Sun Y, Yuan Y, Lau WB, Zheng Q, Wang
X, Wang Y, Shang X, Gao E, Koch WJ, et al: C1q/tumor necrosis
factor-related protein-3, a newly identified adipokine, is a novel
antiapoptotic, proangiogenic, and cardioprotective molecule in the
ischemic mouse heart. Circulation. 125:3159–3169. 2012. View Article : Google Scholar : PubMed/NCBI
|
